Abstract
Human embryonic stem cell lines have the capability to develop into cells representative of the three germ layers of the human body, which has raised the possibility of exciting new opportunities for in vitro research and the development of therapies for the future. However, it is vital that in these pursuits researchers are aware of certain critical issues in sourcing cell lines to ensure that their work provides data of a high standard and does not lead to confusion and that any future use of the cells – such as clinical application – is not compromised by the conditions under which the cells are developed. Stem cell banks have been much discussed in the literature and would appear to have a significant role to play in this important area of endeavour. This chapter places the current development of stem cell banking against the history of bioresource centres and culture collections. It also identifies the different types and roles that stem cell banks may have and as a case study describes the particular remit of the UK Stem Cell Bank and how this influences its policies and procedures. The author goes on to explain the importance of careful development of cell line procurement procedures, the need for standardised banking protocols and the challenges for appropriate supply of pluripotent stem cell lines. In conclusion, the author outlines the importance of international collaboration between the developing network of stem cell banks giving examples of standards (e.g. www.stemcellfoum.org/) that may develop from such activity.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Elstner A, Damaschun A, Kurtz A, Stacey G, Arán B, Veiga A et al. The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res. 2009; 2:101–7. Epub 2008 Nov 17.
Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 2001; 98:8012–7. Epub 2001 Jun 19.
Stacey GN. Cell culture contamination. In Cancer cell culture: methods and protocols. 2010, Ed Cree, IA., Springer, (in press).
Stacey GN. Sourcing human embryonic stem cell lines. In: Human embryonic Stem cells: A practical handbook. Eds. Sullivan S, Cowan C. and Eggan K. John Wiley and Sons Ltd, Chichester, England 2007.
WHO (Expert Committee on Biological Standardization and Executive Board) (1998) Requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for Biological Substances No. 50). WHO Technical Report Series No. 878. Geneva: World Health Organization.
Coecke S, Balls M, Bowe G, Davis J, Gstraunthaler G, Hartung T et al. Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. ATLA 2005; 33:1–27.
Stacey GN, Masters JR. Cryopreservation and banking of mammalian cell lines. Nat Protoc. 2008; 3:1981–9.
Code of practice for the use of stem cell lines, 2010; www.ukstemcellbank.org.uk
Stacey GN, Auerbach JM. Quality control of stem cell lines in Culture of stem cells. Eds Freshney IR, Stacey GN and Auerbach, JM, John Wiley & Sons Inc, Hoboken, New Jersey, USA, 2007 pp 1–22.
Healy L, Hunt C, Young L, Stacey G. The UK Stem Cell Bank: its role as a public research resource center providing access to well-characterised seed stocks of human stem cell lines. Adv Drug Deliv Rev. 2005; 57:1981–8.
Franklin SB, Hunt C, Cornwell G, Peddie V, Desousa P, Livie M et al. hESCCO: development of good practice models for hES cell derivation. Regen Med. 2008; 3:105–16.
International stem cell banking initiative. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. 2009; 5:301–14.
International stem cell initiative. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007; 25:803–16. Epub 2007 Jun 17.
International stem cell initiative consortium. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim. 2010; 46:247–58. Epub 2010 Feb 26.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Appendix 1. Strategic Aims of the UK Stem Cell Bank
Appendix 1. Strategic Aims of the UK Stem Cell Bank
The mission of the UK Stem Cell bank is to assure the quality of stem cells for the scientific and clinical community and the strategy to achieve this will be to:
-
“Focus on banking and supplying tissue specific and pluripotent human stem cell lines that are required, or are likely to be required, for stem cell research and development;
-
Provide associated reference reagents and materials to assist with their growth and characterization;
-
Store all embryonic stem cell lines submitted to the Bank as required by UK legislation;
-
Develop and make readily available a repository of useful technical information to assist the stem cell R&D community;
-
Implement and maintain quality assurance systems that are fit for...
-
Cell lines with significant potential for clinical development, to ensure as far as possible that they are developed in a way that will not compromise their future use for sustained human therapy
-
Other cell lines, to ensure that they are consistent, safe to use in research, and sufficiently well characterized to be of use to recipients.
-
-
Maximize efficiency and minimize bureaucracy related to deposit and release of stem cells while ensuring compliance with steering group/other guidelines and legislative requirements;
-
Provide expert training in technical matters relating to the growth and characterization of stem cells, including GMP cell banking;
-
Carry out high quality scientific research on methodologies for...
-
Improving consistency and propagation of stem cells
-
Developing and improving diagnostic tools for stem cells
-
Improving in vitro safety tests for adventitious agents and pathogens
-
Preservation, storage and distribution of stem cells.
-
-
Promote regulatory mechanisms that facilitate safe and effective development of stem cell therapies;
-
Charge for materials and services fairly and appropriately to help defray costs.”
UK Stem Cell Bank Management Committee, May 2008
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Stacey, G. (2011). Stem Cell Banks: Reality, Roles and Challenges. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-60761-959-8_18
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-958-1
Online ISBN: 978-1-60761-959-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)